Global Amphotericin B for Injection Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.
The global Amphotericin B for Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Amphotericin B for Injection Industry Forecast” looks at past sales and reviews total world Amphotericin B for Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Amphotericin B for Injection sales for 2024 through 2030. With Amphotericin B for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amphotericin B for Injection industry.
This Insight Report provides a comprehensive analysis of the global Amphotericin B for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amphotericin B for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amphotericin B for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amphotericin B for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amphotericin B for Injection.
United States market for Amphotericin B for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Amphotericin B for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Amphotericin B for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Amphotericin B for Injection players cover Gilead Sciences, SPH New Asia Pharmaceuticals, North China Pharmaceutical, Cspc Holdings, Jemincare, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Amphotericin B for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Amphotericin B for Injection market?
What factors are driving Amphotericin B for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amphotericin B for Injection market opportunities vary by end market size?
How does Amphotericin B for Injection break out by Type, by Application?
Amphotericin B is an antifungal medication used for serious fungal infections and leishmaniasis. The fungal infections it is used to treat include mucormycosis, aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, and cryptococcosis.
The global Amphotericin B for Injection market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Amphotericin B for Injection Industry Forecast” looks at past sales and reviews total world Amphotericin B for Injection sales in 2023, providing a comprehensive analysis by region and market sector of projected Amphotericin B for Injection sales for 2024 through 2030. With Amphotericin B for Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Amphotericin B for Injection industry.
This Insight Report provides a comprehensive analysis of the global Amphotericin B for Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Amphotericin B for Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Amphotericin B for Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Amphotericin B for Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Amphotericin B for Injection.
United States market for Amphotericin B for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Amphotericin B for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Amphotericin B for Injection is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Amphotericin B for Injection players cover Gilead Sciences, SPH New Asia Pharmaceuticals, North China Pharmaceutical, Cspc Holdings, Jemincare, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Amphotericin B for Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Common Formulation
- Liposome Formulation
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Gilead Sciences
- SPH New Asia Pharmaceuticals
- North China Pharmaceutical
- Cspc Holdings
- Jemincare
What is the 10-year outlook for the global Amphotericin B for Injection market?
What factors are driving Amphotericin B for Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Amphotericin B for Injection market opportunities vary by end market size?
How does Amphotericin B for Injection break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amphotericin B for Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Amphotericin B for Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Amphotericin B for Injection by Country/Region, 2019, 2023 & 2030
2.2 Amphotericin B for Injection Segment by Type
2.2.1 Common Formulation
2.2.2 Liposome Formulation
2.3 Amphotericin B for Injection Sales by Type
2.3.1 Global Amphotericin B for Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Amphotericin B for Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Amphotericin B for Injection Sale Price by Type (2019-2024)
2.4 Amphotericin B for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Amphotericin B for Injection Sales by Application
2.5.1 Global Amphotericin B for Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Amphotericin B for Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Amphotericin B for Injection Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Amphotericin B for Injection Breakdown Data by Company
3.1.1 Global Amphotericin B for Injection Annual Sales by Company (2019-2024)
3.1.2 Global Amphotericin B for Injection Sales Market Share by Company (2019-2024)
3.2 Global Amphotericin B for Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Amphotericin B for Injection Revenue by Company (2019-2024)
3.2.2 Global Amphotericin B for Injection Revenue Market Share by Company (2019-2024)
3.3 Global Amphotericin B for Injection Sale Price by Company
3.4 Key Manufacturers Amphotericin B for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amphotericin B for Injection Product Location Distribution
3.4.2 Players Amphotericin B for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AMPHOTERICIN B FOR INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Amphotericin B for Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Amphotericin B for Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Amphotericin B for Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Amphotericin B for Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Amphotericin B for Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Amphotericin B for Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Amphotericin B for Injection Sales Growth
4.4 APAC Amphotericin B for Injection Sales Growth
4.5 Europe Amphotericin B for Injection Sales Growth
4.6 Middle East & Africa Amphotericin B for Injection Sales Growth
5 AMERICAS
5.1 Americas Amphotericin B for Injection Sales by Country
5.1.1 Americas Amphotericin B for Injection Sales by Country (2019-2024)
5.1.2 Americas Amphotericin B for Injection Revenue by Country (2019-2024)
5.2 Americas Amphotericin B for Injection Sales by Type (2019-2024)
5.3 Americas Amphotericin B for Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amphotericin B for Injection Sales by Region
6.1.1 APAC Amphotericin B for Injection Sales by Region (2019-2024)
6.1.2 APAC Amphotericin B for Injection Revenue by Region (2019-2024)
6.2 APAC Amphotericin B for Injection Sales by Type (2019-2024)
6.3 APAC Amphotericin B for Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Amphotericin B for Injection by Country
7.1.1 Europe Amphotericin B for Injection Sales by Country (2019-2024)
7.1.2 Europe Amphotericin B for Injection Revenue by Country (2019-2024)
7.2 Europe Amphotericin B for Injection Sales by Type (2019-2024)
7.3 Europe Amphotericin B for Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amphotericin B for Injection by Country
8.1.1 Middle East & Africa Amphotericin B for Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Amphotericin B for Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Amphotericin B for Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Amphotericin B for Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amphotericin B for Injection
10.3 Manufacturing Process Analysis of Amphotericin B for Injection
10.4 Industry Chain Structure of Amphotericin B for Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amphotericin B for Injection Distributors
11.3 Amphotericin B for Injection Customer
12 WORLD FORECAST REVIEW FOR AMPHOTERICIN B FOR INJECTION BY GEOGRAPHIC REGION
12.1 Global Amphotericin B for Injection Market Size Forecast by Region
12.1.1 Global Amphotericin B for Injection Forecast by Region (2025-2030)
12.1.2 Global Amphotericin B for Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Amphotericin B for Injection Forecast by Type (2025-2030)
12.7 Global Amphotericin B for Injection Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Information
13.1.2 Gilead Sciences Amphotericin B for Injection Product Portfolios and Specifications
13.1.3 Gilead Sciences Amphotericin B for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Gilead Sciences Main Business Overview
13.1.5 Gilead Sciences Latest Developments
13.2 SPH New Asia Pharmaceuticals
13.2.1 SPH New Asia Pharmaceuticals Company Information
13.2.2 SPH New Asia Pharmaceuticals Amphotericin B for Injection Product Portfolios and Specifications
13.2.3 SPH New Asia Pharmaceuticals Amphotericin B for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 SPH New Asia Pharmaceuticals Main Business Overview
13.2.5 SPH New Asia Pharmaceuticals Latest Developments
13.3 North China Pharmaceutical
13.3.1 North China Pharmaceutical Company Information
13.3.2 North China Pharmaceutical Amphotericin B for Injection Product Portfolios and Specifications
13.3.3 North China Pharmaceutical Amphotericin B for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 North China Pharmaceutical Main Business Overview
13.3.5 North China Pharmaceutical Latest Developments
13.4 Cspc Holdings
13.4.1 Cspc Holdings Company Information
13.4.2 Cspc Holdings Amphotericin B for Injection Product Portfolios and Specifications
13.4.3 Cspc Holdings Amphotericin B for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Cspc Holdings Main Business Overview
13.4.5 Cspc Holdings Latest Developments
13.5 Jemincare
13.5.1 Jemincare Company Information
13.5.2 Jemincare Amphotericin B for Injection Product Portfolios and Specifications
13.5.3 Jemincare Amphotericin B for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Jemincare Main Business Overview
13.5.5 Jemincare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Amphotericin B for Injection Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Amphotericin B for Injection by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Amphotericin B for Injection by Country/Region, 2019, 2023 & 2030
2.2 Amphotericin B for Injection Segment by Type
2.2.1 Common Formulation
2.2.2 Liposome Formulation
2.3 Amphotericin B for Injection Sales by Type
2.3.1 Global Amphotericin B for Injection Sales Market Share by Type (2019-2024)
2.3.2 Global Amphotericin B for Injection Revenue and Market Share by Type (2019-2024)
2.3.3 Global Amphotericin B for Injection Sale Price by Type (2019-2024)
2.4 Amphotericin B for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Amphotericin B for Injection Sales by Application
2.5.1 Global Amphotericin B for Injection Sale Market Share by Application (2019-2024)
2.5.2 Global Amphotericin B for Injection Revenue and Market Share by Application (2019-2024)
2.5.3 Global Amphotericin B for Injection Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Amphotericin B for Injection Breakdown Data by Company
3.1.1 Global Amphotericin B for Injection Annual Sales by Company (2019-2024)
3.1.2 Global Amphotericin B for Injection Sales Market Share by Company (2019-2024)
3.2 Global Amphotericin B for Injection Annual Revenue by Company (2019-2024)
3.2.1 Global Amphotericin B for Injection Revenue by Company (2019-2024)
3.2.2 Global Amphotericin B for Injection Revenue Market Share by Company (2019-2024)
3.3 Global Amphotericin B for Injection Sale Price by Company
3.4 Key Manufacturers Amphotericin B for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Amphotericin B for Injection Product Location Distribution
3.4.2 Players Amphotericin B for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR AMPHOTERICIN B FOR INJECTION BY GEOGRAPHIC REGION
4.1 World Historic Amphotericin B for Injection Market Size by Geographic Region (2019-2024)
4.1.1 Global Amphotericin B for Injection Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Amphotericin B for Injection Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Amphotericin B for Injection Market Size by Country/Region (2019-2024)
4.2.1 Global Amphotericin B for Injection Annual Sales by Country/Region (2019-2024)
4.2.2 Global Amphotericin B for Injection Annual Revenue by Country/Region (2019-2024)
4.3 Americas Amphotericin B for Injection Sales Growth
4.4 APAC Amphotericin B for Injection Sales Growth
4.5 Europe Amphotericin B for Injection Sales Growth
4.6 Middle East & Africa Amphotericin B for Injection Sales Growth
5 AMERICAS
5.1 Americas Amphotericin B for Injection Sales by Country
5.1.1 Americas Amphotericin B for Injection Sales by Country (2019-2024)
5.1.2 Americas Amphotericin B for Injection Revenue by Country (2019-2024)
5.2 Americas Amphotericin B for Injection Sales by Type (2019-2024)
5.3 Americas Amphotericin B for Injection Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Amphotericin B for Injection Sales by Region
6.1.1 APAC Amphotericin B for Injection Sales by Region (2019-2024)
6.1.2 APAC Amphotericin B for Injection Revenue by Region (2019-2024)
6.2 APAC Amphotericin B for Injection Sales by Type (2019-2024)
6.3 APAC Amphotericin B for Injection Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Amphotericin B for Injection by Country
7.1.1 Europe Amphotericin B for Injection Sales by Country (2019-2024)
7.1.2 Europe Amphotericin B for Injection Revenue by Country (2019-2024)
7.2 Europe Amphotericin B for Injection Sales by Type (2019-2024)
7.3 Europe Amphotericin B for Injection Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Amphotericin B for Injection by Country
8.1.1 Middle East & Africa Amphotericin B for Injection Sales by Country (2019-2024)
8.1.2 Middle East & Africa Amphotericin B for Injection Revenue by Country (2019-2024)
8.2 Middle East & Africa Amphotericin B for Injection Sales by Type (2019-2024)
8.3 Middle East & Africa Amphotericin B for Injection Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Amphotericin B for Injection
10.3 Manufacturing Process Analysis of Amphotericin B for Injection
10.4 Industry Chain Structure of Amphotericin B for Injection
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Amphotericin B for Injection Distributors
11.3 Amphotericin B for Injection Customer
12 WORLD FORECAST REVIEW FOR AMPHOTERICIN B FOR INJECTION BY GEOGRAPHIC REGION
12.1 Global Amphotericin B for Injection Market Size Forecast by Region
12.1.1 Global Amphotericin B for Injection Forecast by Region (2025-2030)
12.1.2 Global Amphotericin B for Injection Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Amphotericin B for Injection Forecast by Type (2025-2030)
12.7 Global Amphotericin B for Injection Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Information
13.1.2 Gilead Sciences Amphotericin B for Injection Product Portfolios and Specifications
13.1.3 Gilead Sciences Amphotericin B for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Gilead Sciences Main Business Overview
13.1.5 Gilead Sciences Latest Developments
13.2 SPH New Asia Pharmaceuticals
13.2.1 SPH New Asia Pharmaceuticals Company Information
13.2.2 SPH New Asia Pharmaceuticals Amphotericin B for Injection Product Portfolios and Specifications
13.2.3 SPH New Asia Pharmaceuticals Amphotericin B for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 SPH New Asia Pharmaceuticals Main Business Overview
13.2.5 SPH New Asia Pharmaceuticals Latest Developments
13.3 North China Pharmaceutical
13.3.1 North China Pharmaceutical Company Information
13.3.2 North China Pharmaceutical Amphotericin B for Injection Product Portfolios and Specifications
13.3.3 North China Pharmaceutical Amphotericin B for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 North China Pharmaceutical Main Business Overview
13.3.5 North China Pharmaceutical Latest Developments
13.4 Cspc Holdings
13.4.1 Cspc Holdings Company Information
13.4.2 Cspc Holdings Amphotericin B for Injection Product Portfolios and Specifications
13.4.3 Cspc Holdings Amphotericin B for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Cspc Holdings Main Business Overview
13.4.5 Cspc Holdings Latest Developments
13.5 Jemincare
13.5.1 Jemincare Company Information
13.5.2 Jemincare Amphotericin B for Injection Product Portfolios and Specifications
13.5.3 Jemincare Amphotericin B for Injection Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Jemincare Main Business Overview
13.5.5 Jemincare Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Amphotericin B for Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Amphotericin B for Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Common Formulation
Table 4. Major Players of Liposome Formulation
Table 5. Global Amphotericin B for Injection Sales by Type (2019-2024) & (K Units)
Table 6. Global Amphotericin B for Injection Sales Market Share by Type (2019-2024)
Table 7. Global Amphotericin B for Injection Revenue by Type (2019-2024) & ($ million)
Table 8. Global Amphotericin B for Injection Revenue Market Share by Type (2019-2024)
Table 9. Global Amphotericin B for Injection Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Amphotericin B for Injection Sale by Application (2019-2024) & (K Units)
Table 11. Global Amphotericin B for Injection Sale Market Share by Application (2019-2024)
Table 12. Global Amphotericin B for Injection Revenue by Application (2019-2024) & ($ million)
Table 13. Global Amphotericin B for Injection Revenue Market Share by Application (2019-2024)
Table 14. Global Amphotericin B for Injection Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Amphotericin B for Injection Sales by Company (2019-2024) & (K Units)
Table 16. Global Amphotericin B for Injection Sales Market Share by Company (2019-2024)
Table 17. Global Amphotericin B for Injection Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Amphotericin B for Injection Revenue Market Share by Company (2019-2024)
Table 19. Global Amphotericin B for Injection Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Amphotericin B for Injection Producing Area Distribution and Sales Area
Table 21. Players Amphotericin B for Injection Products Offered
Table 22. Amphotericin B for Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Amphotericin B for Injection Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Amphotericin B for Injection Sales Market Share Geographic Region (2019-2024)
Table 27. Global Amphotericin B for Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Amphotericin B for Injection Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Amphotericin B for Injection Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Amphotericin B for Injection Sales Market Share by Country/Region (2019-2024)
Table 31. Global Amphotericin B for Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Amphotericin B for Injection Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Amphotericin B for Injection Sales by Country (2019-2024) & (K Units)
Table 34. Americas Amphotericin B for Injection Sales Market Share by Country (2019-2024)
Table 35. Americas Amphotericin B for Injection Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Amphotericin B for Injection Sales by Type (2019-2024) & (K Units)
Table 37. Americas Amphotericin B for Injection Sales by Application (2019-2024) & (K Units)
Table 38. APAC Amphotericin B for Injection Sales by Region (2019-2024) & (K Units)
Table 39. APAC Amphotericin B for Injection Sales Market Share by Region (2019-2024)
Table 40. APAC Amphotericin B for Injection Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Amphotericin B for Injection Sales by Type (2019-2024) & (K Units)
Table 42. APAC Amphotericin B for Injection Sales by Application (2019-2024) & (K Units)
Table 43. Europe Amphotericin B for Injection Sales by Country (2019-2024) & (K Units)
Table 44. Europe Amphotericin B for Injection Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Amphotericin B for Injection Sales by Type (2019-2024) & (K Units)
Table 46. Europe Amphotericin B for Injection Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa Amphotericin B for Injection Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa Amphotericin B for Injection Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Amphotericin B for Injection Sales by Type (2019-2024) & (K Units)
Table 50. Middle East & Africa Amphotericin B for Injection Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Amphotericin B for Injection
Table 52. Key Market Challenges & Risks of Amphotericin B for Injection
Table 53. Key Industry Trends of Amphotericin B for Injection
Table 54. Amphotericin B for Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Amphotericin B for Injection Distributors List
Table 57. Amphotericin B for Injection Customer List
Table 58. Global Amphotericin B for Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 59. Global Amphotericin B for Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Amphotericin B for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 61. Americas Amphotericin B for Injection Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Amphotericin B for Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 63. APAC Amphotericin B for Injection Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Amphotericin B for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Europe Amphotericin B for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Amphotericin B for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa Amphotericin B for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Amphotericin B for Injection Sales Forecast by Type (2025-2030) & (K Units)
Table 69. Global Amphotericin B for Injection Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Amphotericin B for Injection Sales Forecast by Application (2025-2030) & (K Units)
Table 71. Global Amphotericin B for Injection Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Gilead Sciences Basic Information, Amphotericin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Gilead Sciences Amphotericin B for Injection Product Portfolios and Specifications
Table 74. Gilead Sciences Amphotericin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Gilead Sciences Main Business
Table 76. Gilead Sciences Latest Developments
Table 77. SPH New Asia Pharmaceuticals Basic Information, Amphotericin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. SPH New Asia Pharmaceuticals Amphotericin B for Injection Product Portfolios and Specifications
Table 79. SPH New Asia Pharmaceuticals Amphotericin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. SPH New Asia Pharmaceuticals Main Business
Table 81. SPH New Asia Pharmaceuticals Latest Developments
Table 82. North China Pharmaceutical Basic Information, Amphotericin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. North China Pharmaceutical Amphotericin B for Injection Product Portfolios and Specifications
Table 84. North China Pharmaceutical Amphotericin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. North China Pharmaceutical Main Business
Table 86. North China Pharmaceutical Latest Developments
Table 87. Cspc Holdings Basic Information, Amphotericin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Cspc Holdings Amphotericin B for Injection Product Portfolios and Specifications
Table 89. Cspc Holdings Amphotericin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Cspc Holdings Main Business
Table 91. Cspc Holdings Latest Developments
Table 92. Jemincare Basic Information, Amphotericin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Jemincare Amphotericin B for Injection Product Portfolios and Specifications
Table 94. Jemincare Amphotericin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Jemincare Main Business
Table 96. Jemincare Latest Developments
Table 1. Amphotericin B for Injection Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Amphotericin B for Injection Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Common Formulation
Table 4. Major Players of Liposome Formulation
Table 5. Global Amphotericin B for Injection Sales by Type (2019-2024) & (K Units)
Table 6. Global Amphotericin B for Injection Sales Market Share by Type (2019-2024)
Table 7. Global Amphotericin B for Injection Revenue by Type (2019-2024) & ($ million)
Table 8. Global Amphotericin B for Injection Revenue Market Share by Type (2019-2024)
Table 9. Global Amphotericin B for Injection Sale Price by Type (2019-2024) & (US$/Unit)
Table 10. Global Amphotericin B for Injection Sale by Application (2019-2024) & (K Units)
Table 11. Global Amphotericin B for Injection Sale Market Share by Application (2019-2024)
Table 12. Global Amphotericin B for Injection Revenue by Application (2019-2024) & ($ million)
Table 13. Global Amphotericin B for Injection Revenue Market Share by Application (2019-2024)
Table 14. Global Amphotericin B for Injection Sale Price by Application (2019-2024) & (US$/Unit)
Table 15. Global Amphotericin B for Injection Sales by Company (2019-2024) & (K Units)
Table 16. Global Amphotericin B for Injection Sales Market Share by Company (2019-2024)
Table 17. Global Amphotericin B for Injection Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Amphotericin B for Injection Revenue Market Share by Company (2019-2024)
Table 19. Global Amphotericin B for Injection Sale Price by Company (2019-2024) & (US$/Unit)
Table 20. Key Manufacturers Amphotericin B for Injection Producing Area Distribution and Sales Area
Table 21. Players Amphotericin B for Injection Products Offered
Table 22. Amphotericin B for Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Amphotericin B for Injection Sales by Geographic Region (2019-2024) & (K Units)
Table 26. Global Amphotericin B for Injection Sales Market Share Geographic Region (2019-2024)
Table 27. Global Amphotericin B for Injection Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Amphotericin B for Injection Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Amphotericin B for Injection Sales by Country/Region (2019-2024) & (K Units)
Table 30. Global Amphotericin B for Injection Sales Market Share by Country/Region (2019-2024)
Table 31. Global Amphotericin B for Injection Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Amphotericin B for Injection Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Amphotericin B for Injection Sales by Country (2019-2024) & (K Units)
Table 34. Americas Amphotericin B for Injection Sales Market Share by Country (2019-2024)
Table 35. Americas Amphotericin B for Injection Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Amphotericin B for Injection Sales by Type (2019-2024) & (K Units)
Table 37. Americas Amphotericin B for Injection Sales by Application (2019-2024) & (K Units)
Table 38. APAC Amphotericin B for Injection Sales by Region (2019-2024) & (K Units)
Table 39. APAC Amphotericin B for Injection Sales Market Share by Region (2019-2024)
Table 40. APAC Amphotericin B for Injection Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Amphotericin B for Injection Sales by Type (2019-2024) & (K Units)
Table 42. APAC Amphotericin B for Injection Sales by Application (2019-2024) & (K Units)
Table 43. Europe Amphotericin B for Injection Sales by Country (2019-2024) & (K Units)
Table 44. Europe Amphotericin B for Injection Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Amphotericin B for Injection Sales by Type (2019-2024) & (K Units)
Table 46. Europe Amphotericin B for Injection Sales by Application (2019-2024) & (K Units)
Table 47. Middle East & Africa Amphotericin B for Injection Sales by Country (2019-2024) & (K Units)
Table 48. Middle East & Africa Amphotericin B for Injection Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Amphotericin B for Injection Sales by Type (2019-2024) & (K Units)
Table 50. Middle East & Africa Amphotericin B for Injection Sales by Application (2019-2024) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Amphotericin B for Injection
Table 52. Key Market Challenges & Risks of Amphotericin B for Injection
Table 53. Key Industry Trends of Amphotericin B for Injection
Table 54. Amphotericin B for Injection Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Amphotericin B for Injection Distributors List
Table 57. Amphotericin B for Injection Customer List
Table 58. Global Amphotericin B for Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 59. Global Amphotericin B for Injection Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Amphotericin B for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 61. Americas Amphotericin B for Injection Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Amphotericin B for Injection Sales Forecast by Region (2025-2030) & (K Units)
Table 63. APAC Amphotericin B for Injection Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Amphotericin B for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 65. Europe Amphotericin B for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Amphotericin B for Injection Sales Forecast by Country (2025-2030) & (K Units)
Table 67. Middle East & Africa Amphotericin B for Injection Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Amphotericin B for Injection Sales Forecast by Type (2025-2030) & (K Units)
Table 69. Global Amphotericin B for Injection Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Amphotericin B for Injection Sales Forecast by Application (2025-2030) & (K Units)
Table 71. Global Amphotericin B for Injection Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Gilead Sciences Basic Information, Amphotericin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 73. Gilead Sciences Amphotericin B for Injection Product Portfolios and Specifications
Table 74. Gilead Sciences Amphotericin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Gilead Sciences Main Business
Table 76. Gilead Sciences Latest Developments
Table 77. SPH New Asia Pharmaceuticals Basic Information, Amphotericin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 78. SPH New Asia Pharmaceuticals Amphotericin B for Injection Product Portfolios and Specifications
Table 79. SPH New Asia Pharmaceuticals Amphotericin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. SPH New Asia Pharmaceuticals Main Business
Table 81. SPH New Asia Pharmaceuticals Latest Developments
Table 82. North China Pharmaceutical Basic Information, Amphotericin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. North China Pharmaceutical Amphotericin B for Injection Product Portfolios and Specifications
Table 84. North China Pharmaceutical Amphotericin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. North China Pharmaceutical Main Business
Table 86. North China Pharmaceutical Latest Developments
Table 87. Cspc Holdings Basic Information, Amphotericin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Cspc Holdings Amphotericin B for Injection Product Portfolios and Specifications
Table 89. Cspc Holdings Amphotericin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Cspc Holdings Main Business
Table 91. Cspc Holdings Latest Developments
Table 92. Jemincare Basic Information, Amphotericin B for Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Jemincare Amphotericin B for Injection Product Portfolios and Specifications
Table 94. Jemincare Amphotericin B for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Jemincare Main Business
Table 96. Jemincare Latest Developments
LIST OF FIGURES
Figure 1. Picture of Amphotericin B for Injection
Figure 2. Amphotericin B for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amphotericin B for Injection Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Amphotericin B for Injection Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Amphotericin B for Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Amphotericin B for Injection Sales Market Share by Country/Region (2023)
Figure 10. Amphotericin B for Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Common Formulation
Figure 12. Product Picture of Liposome Formulation
Figure 13. Global Amphotericin B for Injection Sales Market Share by Type in 2023
Figure 14. Global Amphotericin B for Injection Revenue Market Share by Type (2019-2024)
Figure 15. Amphotericin B for Injection Consumed in Hospital
Figure 16. Global Amphotericin B for Injection Market: Hospital (2019-2024) & (K Units)
Figure 17. Amphotericin B for Injection Consumed in Clinic
Figure 18. Global Amphotericin B for Injection Market: Clinic (2019-2024) & (K Units)
Figure 19. Amphotericin B for Injection Consumed in Others
Figure 20. Global Amphotericin B for Injection Market: Others (2019-2024) & (K Units)
Figure 21. Global Amphotericin B for Injection Sale Market Share by Application (2023)
Figure 22. Global Amphotericin B for Injection Revenue Market Share by Application in 2023
Figure 23. Amphotericin B for Injection Sales by Company in 2023 (K Units)
Figure 24. Global Amphotericin B for Injection Sales Market Share by Company in 2023
Figure 25. Amphotericin B for Injection Revenue by Company in 2023 ($ millions)
Figure 26. Global Amphotericin B for Injection Revenue Market Share by Company in 2023
Figure 27. Global Amphotericin B for Injection Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Amphotericin B for Injection Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Amphotericin B for Injection Sales 2019-2024 (K Units)
Figure 30. Americas Amphotericin B for Injection Revenue 2019-2024 ($ millions)
Figure 31. APAC Amphotericin B for Injection Sales 2019-2024 (K Units)
Figure 32. APAC Amphotericin B for Injection Revenue 2019-2024 ($ millions)
Figure 33. Europe Amphotericin B for Injection Sales 2019-2024 (K Units)
Figure 34. Europe Amphotericin B for Injection Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Amphotericin B for Injection Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Amphotericin B for Injection Revenue 2019-2024 ($ millions)
Figure 37. Americas Amphotericin B for Injection Sales Market Share by Country in 2023
Figure 38. Americas Amphotericin B for Injection Revenue Market Share by Country (2019-2024)
Figure 39. Americas Amphotericin B for Injection Sales Market Share by Type (2019-2024)
Figure 40. Americas Amphotericin B for Injection Sales Market Share by Application (2019-2024)
Figure 41. United States Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Amphotericin B for Injection Sales Market Share by Region in 2023
Figure 46. APAC Amphotericin B for Injection Revenue Market Share by Region (2019-2024)
Figure 47. APAC Amphotericin B for Injection Sales Market Share by Type (2019-2024)
Figure 48. APAC Amphotericin B for Injection Sales Market Share by Application (2019-2024)
Figure 49. China Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 53. India Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Amphotericin B for Injection Sales Market Share by Country in 2023
Figure 57. Europe Amphotericin B for Injection Revenue Market Share by Country (2019-2024)
Figure 58. Europe Amphotericin B for Injection Sales Market Share by Type (2019-2024)
Figure 59. Europe Amphotericin B for Injection Sales Market Share by Application (2019-2024)
Figure 60. Germany Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 61. France Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Amphotericin B for Injection Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Amphotericin B for Injection Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Amphotericin B for Injection Sales Market Share by Application (2019-2024)
Figure 68. Egypt Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Amphotericin B for Injection in 2023
Figure 74. Manufacturing Process Analysis of Amphotericin B for Injection
Figure 75. Industry Chain Structure of Amphotericin B for Injection
Figure 76. Channels of Distribution
Figure 77. Global Amphotericin B for Injection Sales Market Forecast by Region (2025-2030)
Figure 78. Global Amphotericin B for Injection Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Amphotericin B for Injection Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Amphotericin B for Injection Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Amphotericin B for Injection Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Amphotericin B for Injection Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Amphotericin B for Injection
Figure 2. Amphotericin B for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Amphotericin B for Injection Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Amphotericin B for Injection Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Amphotericin B for Injection Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Amphotericin B for Injection Sales Market Share by Country/Region (2023)
Figure 10. Amphotericin B for Injection Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Common Formulation
Figure 12. Product Picture of Liposome Formulation
Figure 13. Global Amphotericin B for Injection Sales Market Share by Type in 2023
Figure 14. Global Amphotericin B for Injection Revenue Market Share by Type (2019-2024)
Figure 15. Amphotericin B for Injection Consumed in Hospital
Figure 16. Global Amphotericin B for Injection Market: Hospital (2019-2024) & (K Units)
Figure 17. Amphotericin B for Injection Consumed in Clinic
Figure 18. Global Amphotericin B for Injection Market: Clinic (2019-2024) & (K Units)
Figure 19. Amphotericin B for Injection Consumed in Others
Figure 20. Global Amphotericin B for Injection Market: Others (2019-2024) & (K Units)
Figure 21. Global Amphotericin B for Injection Sale Market Share by Application (2023)
Figure 22. Global Amphotericin B for Injection Revenue Market Share by Application in 2023
Figure 23. Amphotericin B for Injection Sales by Company in 2023 (K Units)
Figure 24. Global Amphotericin B for Injection Sales Market Share by Company in 2023
Figure 25. Amphotericin B for Injection Revenue by Company in 2023 ($ millions)
Figure 26. Global Amphotericin B for Injection Revenue Market Share by Company in 2023
Figure 27. Global Amphotericin B for Injection Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Amphotericin B for Injection Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Amphotericin B for Injection Sales 2019-2024 (K Units)
Figure 30. Americas Amphotericin B for Injection Revenue 2019-2024 ($ millions)
Figure 31. APAC Amphotericin B for Injection Sales 2019-2024 (K Units)
Figure 32. APAC Amphotericin B for Injection Revenue 2019-2024 ($ millions)
Figure 33. Europe Amphotericin B for Injection Sales 2019-2024 (K Units)
Figure 34. Europe Amphotericin B for Injection Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa Amphotericin B for Injection Sales 2019-2024 (K Units)
Figure 36. Middle East & Africa Amphotericin B for Injection Revenue 2019-2024 ($ millions)
Figure 37. Americas Amphotericin B for Injection Sales Market Share by Country in 2023
Figure 38. Americas Amphotericin B for Injection Revenue Market Share by Country (2019-2024)
Figure 39. Americas Amphotericin B for Injection Sales Market Share by Type (2019-2024)
Figure 40. Americas Amphotericin B for Injection Sales Market Share by Application (2019-2024)
Figure 41. United States Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC Amphotericin B for Injection Sales Market Share by Region in 2023
Figure 46. APAC Amphotericin B for Injection Revenue Market Share by Region (2019-2024)
Figure 47. APAC Amphotericin B for Injection Sales Market Share by Type (2019-2024)
Figure 48. APAC Amphotericin B for Injection Sales Market Share by Application (2019-2024)
Figure 49. China Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 53. India Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe Amphotericin B for Injection Sales Market Share by Country in 2023
Figure 57. Europe Amphotericin B for Injection Revenue Market Share by Country (2019-2024)
Figure 58. Europe Amphotericin B for Injection Sales Market Share by Type (2019-2024)
Figure 59. Europe Amphotericin B for Injection Sales Market Share by Application (2019-2024)
Figure 60. Germany Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 61. France Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 62. UK Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa Amphotericin B for Injection Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa Amphotericin B for Injection Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa Amphotericin B for Injection Sales Market Share by Application (2019-2024)
Figure 68. Egypt Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries Amphotericin B for Injection Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Amphotericin B for Injection in 2023
Figure 74. Manufacturing Process Analysis of Amphotericin B for Injection
Figure 75. Industry Chain Structure of Amphotericin B for Injection
Figure 76. Channels of Distribution
Figure 77. Global Amphotericin B for Injection Sales Market Forecast by Region (2025-2030)
Figure 78. Global Amphotericin B for Injection Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global Amphotericin B for Injection Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global Amphotericin B for Injection Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global Amphotericin B for Injection Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global Amphotericin B for Injection Revenue Market Share Forecast by Application (2025-2030)
